Loading...
Loading...
MRK| Name | Value |
|---|---|
| Revenues | 16.7B |
| Cost of Revenue | 4.1B |
| Gross Profit | 12.6B |
| Operating Expense | 8.5B |
| Operating I/L | 4.0B |
| Other Income/Expense | 0.1B |
| Interest Income | 0.1B |
| Pretax | 4.1B |
| Income Tax Expense | 0.9B |
| Net Income/Loss | 3.2B |
Merck & Co., Inc. is a global healthcare company with two main segments: Pharmaceutical and Animal Health. The Pharmaceutical segment focuses on a wide range of human health pharmaceutical products, including oncology, immunology, cardiovascular, and vaccines. The Animal Health segment offers veterinary pharmaceuticals, vaccines, and health management solutions. The company serves various entities, including drug wholesalers, hospitals, managed healthcare providers, physicians, veterinarians, and animal producers. Additionally, it engages in collaborations with leading pharmaceutical companies to develop and commercialize long-acting treatments in HIV, contributing to its revenue streams.
